Global Drug Discovery Technologies 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR062415585

Publication Date:

June 27, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Drug Discovery Technologies market size was valued at USD 49380 million in 2023 and is forecast to a readjusted size of USD 76490 million by 2030 with a CAGR of 6.5% during review period.
This report mainly focuses on drug discovery technologies marekt. Current drug discovery technologies aims to discover all the modern techniques and technologies used in drug discovery.
Regionally, North America will dominate the global drug discovery technologies market in 2022. Countries such as the United States lead the world in R&D spending. Furthermore, increasing demand for advanced and innovative medicines due to increasing prevalence of chronic diseases is driving the growth of the drug discovery market in North America. Asia Pacific is estimated to be the most opportunistic market in the coming years. This can be attributed to the presence of numerous CROs in the region. Moreover, countries such as South Korea, India, and China are investing heavily in the development of the pharmaceutical industry, which is fueling the demand for biopharmaceutical products.
This report includes an overview of the development of the Drug Discovery Technologies industry chain, the market status of Pharmaceutical Companies (Small-molecule Drugs, Biologics), Research Institutes (Small-molecule Drugs, Biologics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drug Discovery Technologies.
Regionally, the report analyzes the Drug Discovery Technologies markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drug Discovery Technologies market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Drug Discovery Technologies market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drug Discovery Technologies industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Small-molecule Drugs, Biologics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drug Discovery Technologies market.
Regional Analysis: The report involves examining the Drug Discovery Technologies market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drug Discovery Technologies market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Drug Discovery Technologies:
Company Analysis: Report covers individual Drug Discovery Technologies players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drug Discovery Technologies This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Companies, Research Institutes).
Technology Analysis: Report covers specific technologies relevant to Drug Discovery Technologies. It assesses the current state, advancements, and potential future developments in Drug Discovery Technologies areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drug Discovery Technologies market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Drug Discovery Technologies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Small-molecule Drugs
Biologics
麻豆原创 segment by Application
Pharmaceutical Companies
Research Institutes
Others
麻豆原创 segment by players, this report covers
Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug Discovery Technologies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Discovery Technologies, with revenue, gross margin and global market share of Drug Discovery Technologies from 2019 to 2024.
Chapter 3, the Drug Discovery Technologies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drug Discovery Technologies market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Discovery Technologies.
Chapter 13, to describe Drug Discovery Technologies research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Drug Discovery Technologies
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Drug Discovery Technologies by Type
1.3.1 Overview: Global Drug Discovery Technologies 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Drug Discovery Technologies Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Small-molecule Drugs
1.3.4 Biologics
1.4 Global Drug Discovery Technologies 麻豆原创 by Application
1.4.1 Overview: Global Drug Discovery Technologies 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical Companies
1.4.3 Research Institutes
1.4.4 Others
1.5 Global Drug Discovery Technologies 麻豆原创 Size & Forecast
1.6 Global Drug Discovery Technologies 麻豆原创 Size and Forecast by Region
1.6.1 Global Drug Discovery Technologies 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Drug Discovery Technologies 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Drug Discovery Technologies 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Drug Discovery Technologies 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Drug Discovery Technologies 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Drug Discovery Technologies 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Drug Discovery Technologies 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Agilent
2.1.1 Agilent Details
2.1.2 Agilent Major Business
2.1.3 Agilent Drug Discovery Technologies Product and Solutions
2.1.4 Agilent Drug Discovery Technologies Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Agilent Recent Developments and Future Plans
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Drug Discovery Technologies Product and Solutions
2.2.4 GE Healthcare Drug Discovery Technologies Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 GE Healthcare Recent Developments and Future Plans
2.3 Albany Molecular Research Inc.
2.3.1 Albany Molecular Research Inc. Details
2.3.2 Albany Molecular Research Inc. Major Business
2.3.3 Albany Molecular Research Inc. Drug Discovery Technologies Product and Solutions
2.3.4 Albany Molecular Research Inc. Drug Discovery Technologies Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Albany Molecular Research Inc. Recent Developments and Future Plans
2.4 Affymetrix
2.4.1 Affymetrix Details
2.4.2 Affymetrix Major Business
2.4.3 Affymetrix Drug Discovery Technologies Product and Solutions
2.4.4 Affymetrix Drug Discovery Technologies Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Affymetrix Recent Developments and Future Plans
2.5 Bayer Healthcare
2.5.1 Bayer Healthcare Details
2.5.2 Bayer Healthcare Major Business
2.5.3 Bayer Healthcare Drug Discovery Technologies Product and Solutions
2.5.4 Bayer Healthcare Drug Discovery Technologies Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Bayer Healthcare Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Drug Discovery Technologies Product and Solutions
2.6.4 Novartis Drug Discovery Technologies Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Novartis Recent Developments and Future Plans
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Drug Discovery Technologies Product and Solutions
2.7.4 AstraZeneca Drug Discovery Technologies Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 AstraZeneca Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Drug Discovery Technologies Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Drug Discovery Technologies by Company Revenue
3.2.2 Top 3 Drug Discovery Technologies Players 麻豆原创 Share in 2023
3.2.3 Top 6 Drug Discovery Technologies Players 麻豆原创 Share in 2023
3.3 Drug Discovery Technologies 麻豆原创: Overall Company Footprint Analysis
3.3.1 Drug Discovery Technologies 麻豆原创: Region Footprint
3.3.2 Drug Discovery Technologies 麻豆原创: Company Product Type Footprint
3.3.3 Drug Discovery Technologies 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Drug Discovery Technologies Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Drug Discovery Technologies 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Drug Discovery Technologies Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Drug Discovery Technologies 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Drug Discovery Technologies Consumption Value by Type (2019-2030)
6.2 North America Drug Discovery Technologies Consumption Value by Application (2019-2030)
6.3 North America Drug Discovery Technologies 麻豆原创 Size by Country
6.3.1 North America Drug Discovery Technologies Consumption Value by Country (2019-2030)
6.3.2 United States Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Drug Discovery Technologies Consumption Value by Type (2019-2030)
7.2 Europe Drug Discovery Technologies Consumption Value by Application (2019-2030)
7.3 Europe Drug Discovery Technologies 麻豆原创 Size by Country
7.3.1 Europe Drug Discovery Technologies Consumption Value by Country (2019-2030)
7.3.2 Germany Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Technologies Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Drug Discovery Technologies Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Drug Discovery Technologies 麻豆原创 Size by Region
8.3.1 Asia-Pacific Drug Discovery Technologies Consumption Value by Region (2019-2030)
8.3.2 China Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Drug Discovery Technologies Consumption Value by Type (2019-2030)
9.2 South America Drug Discovery Technologies Consumption Value by Application (2019-2030)
9.3 South America Drug Discovery Technologies 麻豆原创 Size by Country
9.3.1 South America Drug Discovery Technologies Consumption Value by Country (2019-2030)
9.3.2 Brazil Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Technologies Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Drug Discovery Technologies Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Drug Discovery Technologies 麻豆原创 Size by Country
10.3.1 Middle East & Africa Drug Discovery Technologies Consumption Value by Country (2019-2030)
10.3.2 Turkey Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Drug Discovery Technologies 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Drug Discovery Technologies 麻豆原创 Drivers
11.2 Drug Discovery Technologies 麻豆原创 Restraints
11.3 Drug Discovery Technologies Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Drug Discovery Technologies Industry Chain
12.2 Drug Discovery Technologies Upstream Analysis
12.3 Drug Discovery Technologies Midstream Analysis
12.4 Drug Discovery Technologies Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.